| Drug Type Small molecule drug | 
| Synonyms Tandrilax | 
| Target | 
| Action antagonists, inhibitors | 
| Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), COX inhibitors(Cyclooxygenases inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC8H10N4O2 | 
| InChIKeyRYYVLZVUVIJVGH-UHFFFAOYSA-N | 
| CAS Registry58-08-2 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Pain | Brazil  | - | 





